San Diego, CA (PRWEB) April 24, 2014
Rancho BioSciences, the scientific data consulting curation company announced today that they will be holding a webinar, hosted by Orion BioNetworks, that discusses the role of the gut microbiome on MS risk and progression. Stephen Wicks, PhD, will be outlining a project that will identify enterotypes that are associated with measures of disease susceptibility and progression. The bacterial genotypes in the study will be correlated with human host genomic information to identify metagenomic factors that predict disease. The webinar will be on May 6th at 9am West coast and 12pm East coast. Interested attendees can find more information at http://www.ranchobiosciences.com.
“There are intriguing suggestions that the microbiome can have profound effects on inflammatory and immune responces system wide. We are excited to explore the interaction of the microbiome with the host genome, and its impact on MS predisposition and progression,” said Wicks. “The microbiome is accessible, and pliable. If we can identify enterotypes, or human-bacterial genomic interactions that help susceptible individuals resist disease progression, avenues to effective and affordable therapies might be available. Our approach, coupled with the incredibly rich data coming from Orion, will certainly be applicable to other disease areas.”
According to Magali Haas, MD,PhD, Founder and CEO of Orion, “the microbiome represents an important environmental contributor in the systems medicine approach that Orion Bionetworks is spearheading for brain disease. We are excited about incorporating this component of the biology into our understanding of MS and other brain diseases.”
About Rancho BioSciences
Rancho BioSciences is a fee-for-service data-curation consulting company leveraging open-source tools and public-domain data. Our customers include Pharma, Institutes, and Academics.
We have a team of experienced Ph.D. and M.D. scientists around the world that deliver high quality work based on their expertise and domain knowledge in biology, diseases, and clinical data. Rancho BioSciences is flexible and cost effective, providing on site and off site curators.
Rancho BioSciences also has expertise in databases and hosts or installs tranSMART for their customers.
Our goal is to help the life-science community build better tools and take advantage of a wealth of scientific data by supporting and developing open source platforms.
For more information about Rancho BioSciences, please visit us online at http://www.ranchobiosciences.com.
About Orion Bionetworks
Orion Bionetworks is a nonprofit dedicated to accelerating the discovery of next-generation diagnostics, treatments, and cures for brain disorders. Led by CEO and founder Magali Haas, MD, PhD, Orion is convening a cooperative alliance of network partners who share a common goal of harnessing the power of high-performance computing and data analytics to discover and develop predictive disease models from integrated biomarker, biosensor and phenotypic data.
Orion is based in Cambridge, MA, with alliance partners across North America and Europe. Orion’s vision is to apply this cooperative, multidisciplinary approach to many brain disorders, beginning with a pilot program for Multiple Sclerosis (MS) and neurodegenerative disorders. For more information please visit http://www.OrionBionetworks.org.